SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Shanghai Junshi Biosciences Says Js103 Injection Received Clinical Trial Approval From NMPA

05/12/2021 06:10
BRIEF-Shanghai Junshi Biosciences Says Js103 Injection Received Clinical Trial Approval From NMPA

- Shanghai Junshi Biosciences Co Ltd 688180.SS

  • JS103 INJECTION RECEIVED CLINICAL TRIAL APPROVAL

Source text for Eikon: ID:nHKS3cvTLs

Further company coverage: 688180.SS


(([email protected];))